These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27908829)

  • 1. Exploring the binding mechanism of Heteroaryldihydropyrimidines and Hepatitis B Virus capsid combined 3D-QSAR and molecular dynamics.
    Tu J; Li JJ; Shan ZJ; Zhai HL
    Antiviral Res; 2017 Jan; 137():151-164. PubMed ID: 27908829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new series of HAPs as anti-HBV agents targeting at capsid assembly.
    Yang XY; Xu XQ; Guan H; Wang LL; Wu Q; Zhao GM; Li S
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4247-9. PubMed ID: 25127104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heteroaryldihydropyrimidines Alter Capsid Assembly By Adjusting the Binding Affinity and Pattern of the Hepatitis B Virus Core Protein.
    Liu H; Okazaki S; Shinoda W
    J Chem Inf Model; 2019 Dec; 59(12):5104-5110. PubMed ID: 31756297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Heteroaryldihydropyrimidine Bay 38-7690 Induces Hepatitis B Virus Core Protein Aggregates Associated with Promyelocytic Leukemia Nuclear Bodies in Infected Cells.
    Huber AD; Wolf JJ; Liu D; Gres AT; Tang J; Boschert KN; Puray-Chavez MN; Pineda DL; Laughlin TG; Coonrod EM; Yang Q; Ji J; Kirby KA; Wang Z; Sarafianos SG
    mSphere; 2018 Apr; 3(2):. PubMed ID: 29669885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms of tetrahydropyrrolo[1,2-c]pyrimidines as HBV capsid assembly inhibitors.
    Song LT; Liu RR; Zhai HL; Meng YJ; Zhu M
    Arch Biochem Biophys; 2019 Mar; 663():1-10. PubMed ID: 30593769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and Pre-Clinical Characterization of Third-Generation 4-H Heteroaryldihydropyrimidine (HAP) Analogues as Hepatitis B Virus (HBV) Capsid Inhibitors.
    Qiu Z; Lin X; Zhang W; Zhou M; Guo L; Kocer B; Wu G; Zhang Z; Liu H; Shi H; Kou B; Hu T; Hu Y; Huang M; Yan SF; Xu Z; Zhou Z; Qin N; Wang YF; Ren S; Qiu H; Zhang Y; Zhang Y; Wu X; Sun K; Zhong S; Xie J; Ottaviani G; Zhou Y; Zhu L; Tian X; Shi L; Shen F; Mao Y; Zhou X; Gao L; Young JAT; Wu JZ; Yang G; Mayweg AV; Shen HC; Tang G; Zhu W
    J Med Chem; 2017 Apr; 60(8):3352-3371. PubMed ID: 28339215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel non-heteroarylpyrimidine (HAP) capsid assembly modifiers have a different mode of action from HAPs in vitro.
    Corcuera A; Stolle K; Hillmer S; Seitz S; Lee JY; Bartenschlager R; Birkmann A; Urban A
    Antiviral Res; 2018 Oct; 158():135-142. PubMed ID: 30031759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Factors Promoting HBV Capsid Self-Assembly by Assembly-Promoting Antivirals.
    Rath SL; Liu H; Okazaki S; Shinoda W
    J Chem Inf Model; 2018 Feb; 58(2):328-337. PubMed ID: 29309148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small-molecule effectors of hepatitis B virus capsid assembly give insight into virus life cycle.
    Bourne C; Lee S; Venkataiah B; Lee A; Korba B; Finn MG; Zlotnick A
    J Virol; 2008 Oct; 82(20):10262-70. PubMed ID: 18684823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of aminothiazole based Hepatitis B Virus (HBV) capsid inhibitors.
    Pan T; Ding Y; Wu L; Liang L; He X; Li Q; Bai C; Zhang H
    Eur J Med Chem; 2019 Mar; 166():480-501. PubMed ID: 30739828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2,4-Diaryl-4,6,7,8-tetrahydroquinazolin-5(1H)-one derivatives as anti-HBV agents targeting at capsid assembly.
    Zhu X; Zhao G; Zhou X; Xu X; Xia G; Zheng Z; Wang L; Yang X; Li S
    Bioorg Med Chem Lett; 2010 Jan; 20(1):299-301. PubMed ID: 19897363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A heteroaryldihydropyrimidine activates and can misdirect hepatitis B virus capsid assembly.
    Stray SJ; Bourne CR; Punna S; Lewis WG; Finn MG; Zlotnick A
    Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8138-43. PubMed ID: 15928089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The novel compound Z060228 inhibits assembly of the HBV capsid.
    Guan H; Zhao G; Chen W; Wu G; Liu H; Jiang X; Li S; Wang LL
    Life Sci; 2015 Jul; 133():1-7. PubMed ID: 25921762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antiviral evaluation of novel heteroarylpyrimidines analogs as HBV capsid effectors.
    Boucle S; Lu X; Bassit L; Ozturk T; Russell OO; Amblard F; Coats SJ; Schinazi RF
    Bioorg Med Chem Lett; 2017 Feb; 27(4):904-910. PubMed ID: 28094179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and Synthesis of Orally Bioavailable 4-Methyl Heteroaryldihydropyrimidine Based Hepatitis B Virus (HBV) Capsid Inhibitors.
    Qiu Z; Lin X; Zhou M; Liu Y; Zhu W; Chen W; Zhang W; Guo L; Liu H; Wu G; Huang M; Jiang M; Xu Z; Zhou Z; Qin N; Ren S; Qiu H; Zhong S; Zhang Y; Zhang Y; Wu X; Shi L; Shen F; Mao Y; Zhou X; Yang W; Wu JZ; Yang G; Mayweg AV; Shen HC; Tang G
    J Med Chem; 2016 Aug; 59(16):7651-66. PubMed ID: 27458651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heteroaryldihydropyrimidine (HAP) and Sulfamoylbenzamide (SBA) Inhibit Hepatitis B Virus Replication by Different Molecular Mechanisms.
    Zhou Z; Hu T; Zhou X; Wildum S; Garcia-Alcalde F; Xu Z; Wu D; Mao Y; Tian X; Zhou Y; Shen F; Zhang Z; Tang G; Najera I; Yang G; Shen HC; Young JA; Qin N
    Sci Rep; 2017 Feb; 7():42374. PubMed ID: 28205569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a Fluorescent Analogue of a HBV Core Protein-Directed Drug To Interrogate an Antiviral Mechanism.
    Nair S; Li L; Francis S; Turner WW; VanNieuwenhze M; Zlotnick A
    J Am Chem Soc; 2018 Nov; 140(45):15261-15269. PubMed ID: 30375863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of small synthetic molecules targeting HBV capsid assembly.
    Liu N; Zhao F; Zhan P; Liu X
    Med Chem; 2015; 11(8):710-6. PubMed ID: 25985859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Dynamics Simulations to Determine the Structure and Dynamics of Hepatitis B Virus Capsid Bound to a Novel Anti-viral Drug.
    Watanabe G; Sato S; Iwadate M; Umeyama H; Hayakawa M; Murakami Y; Yoneda S
    Chem Pharm Bull (Tokyo); 2016; 64(9):1393-6. PubMed ID: 27581644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, diversity-oriented synthesis and biological evaluation of novel heterocycle derivatives as non-nucleoside HBV capsid protein inhibitors.
    Jia H; Yu J; Du X; Cherukupalli S; Zhan P; Liu X
    Eur J Med Chem; 2020 Sep; 202():112495. PubMed ID: 32712535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.